All Updates

WASHINGTON, D.C. August 25, 2014 Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) on the Drug Enforcement Administration 's (DEA) move to restrict access to hydrocodone combination products. ACS CAN submitted comments to the DEA earlier this year in opposition to the proposed move.

The following statement comes from Chris Hansen, president of the American Cancer Society Cancer Action Network, in response to new data from the Centers for Disease Control and Prevention (CDC) showing a three-fold increase in the number of youth using e-cigarettes who don 't smoke conventional cigarettes.

WASHINGTON, D.C. August 21, 2014 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). As the changing health care landscape presents new opportunities to prevent a

WASHINGTON, DC -- In public comments jointly filed today , 24 leading public health and medical organizations called on the Food and Drug Administration to issue a final rule to regulate all tobacco products by April 25, 2015 -- one year after the FDA issued a proposed rule --

Updated August 4, 2014 WASHINGTON, D.C. -- July 31, 2014 -- The Food and Drug Administration (FDA) today announced its intention to release a draft framework to regulate laboratory developed tests (LDTs) that are used for making critical diagnostic and treatment decisions made by patients and their health care